Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Am J Obstet Gynecol. 2013 Jul 11;209(5):10.1016/j.ajog.2013.07.003. doi: 10.1016/j.ajog.2013.07.003

The Combined Association of Psychosocial Stress and Chronic Hypertension with Preeclampsia

Yunxian Yu 1, Shanchun Zhang 1, Eric B Mallow 2, Guoying Wang 2, Xiumei Hong 2, Sheila O Walker 2, Colleen Pearson 3, Linda Heffner 4, Barry Zuckerman 3, Xiaobin Wang 2
PMCID: PMC3825759  NIHMSID: NIHMS504623  PMID: 23850528

Abstract

OBJECTIVE

This study aims to evaluate perceived lifetime stress (LS), perceived stress during pregnancy (PS), chronic hypertension (CH) and their joint association with preeclampsia risk.

STUDY DESIGN

This study includes 4,314 women who delivered a singleton live birth at the Boston Medical Center from October 1998 through February 2008. CH is defined as hypertension diagnosed before pregnancy. Information regarding LS and SP was collected by questionnaire. Preeclampsia was diagnosed by clinical criteria.

RESULTS

LS, SP and CH were each associated with an increased risk of preeclampsia (OR(95%CI)=2.1(1.6–2.8) for LS; 1.7(1.3–2.1) for SP; 11.1(8.1–15.4) for CH). Compared with normotensive pregnancy with low LS, both normotensive pregnancy with high LS (2.1(1.5–2.9)) and pregnancy with CH and low LS (10.6(7.5–15.1)) showed an increased risk of preeclampsia, while pregnancy with high LS and CH yielded the highest risk of preeclampsia (21.3(10.3–44.3)). The joint association of SP and CH on preeclampsia was very similar to that of the joint association of LS and CH.

CONCLUSIONS

This finding indicates that high psychosocial stress and CH can act in combination to increase the risk of preeclampsia up to 20-fold. This finding underscores the importance of efforts to prevent, screen and manage CH, along with reducing psychosocial stress, particularly among women with CH.

Keywords: Psychosocial stress, chronic hypertension, combined effect, preeclampsia

Introduction

Preeclampsia occurs in 5–7% of pregnancies, and is a major cause of maternal and fetal mortality and morbidity in both developed and developing countries. Onset early in pregnancy is associated with a poorer prognosis. For the fetus, preeclampsia may result in growth retardation, preterm birth, hypoxia, and death. For the mother, it may induce placental abruption with possible disseminated intravascular coagulation, end organ damage as a result of accelerated hypertension, stroke, and death1. Women who have preeclampsia as a multipara, as a recurrent event, or who develop it in the second trimester have been found to be at higher risk for hypertension and diabetes later in life2. Worldwide, 10–15% of the half million maternal deaths that occur every year are associated with hypertensive disorders of pregnancy, mainly preeclampsia/eclampsia (PE/E)3. In Canada, PE/E was one of the leading causes of maternal death in 1997–2000, accounting directly for 21% of maternal deaths4.

Previous studies have found that women with certain conditions, including nulliparity, a family or self-history of preeclampsia, increased body mass index (BMI), multiple pregnancies, increased age, chronic hypertension, diabetes mellitus, renal and connective tissue diseases, work-related psychosocial strain during pregnancy, poor social status, diabetes mellitus, coagulation abnormalities, and dyslipidemia are at increased risk for preeclampsia2,5. Of note, chronic hypertension is a well-known risk factor for preeclampsia. Its prevalence in pregnant women varies from 1% to 5%; and the rates are higher in older, obese, or black women6. It is estimated that 25% of women with preexisting hypertension will have PE/E during pregnancy7. In Thailand, pregnant women with chronic hypertension had a 19.5-fold (95%CI=2.4–155.7) increased risk of preeclampsia, compared with those without chronic hypertension5. Previously, our study group found that chronic hypertension was associated with preeclampsia among African and White pregnant women8. In short, data from different studies have consistently shown that chronic hypertension is a leading cause of PE/E58.

In contrast, findings to date on psychosocial stress and PE/E have been inconsistent. Some studies found depression, anxiety, and other psychopathologies during pregnancy to be risk factors for adverse fetal and neonatal outcomes including preterm delivery911, fetal growth restriction12, and low Apgar scores13. In addition, mothers’ anxiety during pregnancy is associated with an increased risk of asthma in children14. Indeed, accumulating evidence indicates that psychiatric disorders during pregnancy are related to an increased risk of preeclampsia. One prospective study indicated that women with depression, anxiety, or both had a 3.1-fold increased risk for preeclampsia, compared to those without them15. Another recent study (by Qiu et al.) found that a positive history of maternal mood or anxiety disorder was associated with a 2.12-fold increased risk of preeclampsia16. Four further studies observed an association of preeclampsia/gestational hypertension with job stress in working women1720, and anther demonstrated that anxiety during early pregnancy increased the risk of preeclampsia more than three-fold among 652 Finnish nulliparous women (OR=3.2; 95%CI =1.4–7.4)15. Likewise, both depression and perceived stress during pregnancy were associated with increased rates of preeclampsia15,21.

Data from animal studies have indicated that in 14-day pregnant rats, chronic stress leads to increased adrenal weight and lower endothelium-derived relaxing factor release; likewise, in 20-day pregnant rats, chronic stress caused higher blood pressure, increased vasomotility and proteinuria, and lower endothelium-derived relaxing factor release22. The animal data also implies that mental stress during pregnancy may increase the risk of hypertension-associated disorders. In contrast with these animal findings, there was no association between work stress, anxiety, depression or pregnancy-related anxiety early in pregnancy and the development of gestational hypertension or preeclampsia later in pregnancy among a cohort of 3679 pregnant women in Amsterdam23. Two other prospective studies did not observe an association between depression or anxiety and hypertensive complications24,25, and moreover, these studies also did not find a significant association between maternal psychopathology and preeclampsia2325.

To date, no study has examined the combined association of psychosocial stress and chronic hypertension with PE/E in a U.S. urban minority population, in which both psychosocial risk factors and chronic hypertension are prevalent. The objectives of this study are to examine the individual and joint association of psychosocial stress and chronic hypertension with preeclampsia in a U.S. urban population, and to explore whether the associations differ between black and non-black women.

Materials and Methods

Study population and data collection

This study is part of an ongoing NIH-funded case-control study on preterm birth, and includes women enrolled at the Boston Medical Center (BMC) from October 1998 to February 2008. The parent study (1998 to present) is being conducted at the BMC, a large urban hospital with a predominantly minority, inner-city patient population. Case mothers were those who delivered singleton, live births occurring at <37 weeks of gestation, and controls were defined as mothers delivering at ≥37 weeks of gestation with birth weight appropriate for gestational age as defined by the National Center for Health Statistics/Centers for Disease Control and Prevention guidelines (birth weight 2500–4000 g)26. Pregnancies resulting in multiple births and newborns with major birth defects were excluded, and a detailed description of the study population is available elsewhere27. For the present study, we collected epidemiologic data, clinical data, and maternal venous blood samples. In addition, placenta samples were sent for histopathology based on routine indications, including preterm birth. The Institutional Review Boards of BMC, the Massachusetts Department of Public Health, Children’s Memorial Hospital in Chicago, and the Johns Hopkins Bloomberg School of Public Health approved the study protocol, and all participants gave written informed consent.

Definition of preeclampsia and other key variables

Preeclampsia and chronic hypertension

All of the following key outcomes were defined by physician diagnosis and confirmed by a review of prenatal care records in accordance with published clinical studies28. Preeclampsia was defined according to the report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy29, as systolic blood pressure ≥ 140 mm Hg or diastolic blood pressure ≥ 90 mm Hg on at least two occasions, and proteinuria of at least 1+ by urine dipstick testing on two or more occasions, after 20 weeks of gestation. In the present study, the preeclampsia group also included women with eclampsia. Women with gestational hypertension, defined as elevated blood pressure occurring after 20 weeks of gestation without preexisting hypertension, and not associated with proteinuria or other systemic manifestations, were excluded from the analysis. Chronic hypertension was defined as persistent hypertension that is present before conception or during the first 20 weeks of gestation.

Variables of psychological stress

We examined the following variables: women’s perceived amount of general life stress, perceived stress during pregnancy, major stressful life events within 1 year prior to pregnancy, major stressful life events during pregnancy, any violence witnessed during pregnancy, father of baby involved in index pregnancy, father of baby supportiveness, family and friend supportiveness, whether pregnancy was desired, annual household income, and food supply. Information about psychological stress was collected by questionnaire. Lifetime Stress (LS) and Stress during Pregnancy (PS) were defined respectively by responses to the following two questions: “How would you characterize the amount of stress in your life in general?” and “How would you characterize the amount of stress in your life during pregnancy?” Three options for these questions were provided: “Not stressful”, “Average stressful” and “Very stressful”. For the analyses, “Not stressful” and “Average stressful” were considered to be low stress; “Very stressful” was regarded as high stress.

Statistical Analysis

All analyses were conducted using SAS software (version 8.0; SAS Institute Inc., Cary, NC). First, the sociodemographic and clinical variables were described, stratified by non-preeclampsia and preeclampsia. The continuous and categorical variables were analyzed by t test and χ 2 test, respectively. Second, the distributions of variables related to psychological stress were presented, stratified by the non-preeclampsia and preeclampsia groups. Third, the separate association of life stress, pregnancy stress, and either life or pregnancy stress combined with chronic hypertension relative to the risk of preeclampsia was analyzed before and after the adjustment of covariates using logistic regression models. Finally, the adjusted joint effect of life stress, pregnancy stress, and chronic hypertension on the risk of preeclampsia were evaluated for entire study samples as well as ethnic subgroups (black and non-black mothers), using logistic regression models.

In the logistic regression models, the following covariates were included: maternal ethnicity, maternal active and passive smoking during pregnancy, maternal age, pre-pregnancy BMI, parity, drug use and alcohol use.

Results

Altogether, 4314 mothers were included in the final analysis, including 3890 mothers without preeclampsia and 424 mothers with preeclampsia. The prevalence of preeclampsia was 9.9% in the study population. Table 1 shows the demographic and clinical characteristics of the study sample. As compared to those without preeclampsia, mothers with preeclampsia were older, had higher pre-pregnancy BMI, and had delivered babies with lower gestational age and/or lower birthweight (all P < 0.001). Mothers with preeclampsia were more likely to be black and primiparous, and have a lower prevalence of active smoking and chronic hypertension (all P < 0.01). The prevalence of passive smoking, illicit drug use and alcohol drinking during pregnancy were similar between the two groups (all P > 0.05).

Table 1.

Study Population Characteristics.

Variable No Preeclampsia Preeclampsia P
N 3890 424
Maternal age, in years (Mean ± SD) 27.8±6.4 29.3±6.9 <0.001
Pre-pregnancy BMI, kg/m2 (Mean
± SD)
25.6±6.0 28.2±7.1 <0.001
Gestational age, in weeks (Mean ±
SD)
38.2±3.2 35.3±3.7 <0.001
Birth weight, in grams (Mean ± SD) 3015.9±743.9 2332.3±898.4 <0.001
Maternal Age Distribution, n(%)
<19 years 453(11.6) 41(9.7) <0.001
20~ years 2027(52.1) 178(42.0)
30~ years 820(21.1) 109(25.7)
>=35 years 590(15.2) 96(22.6)
Highest Education Completed n(%)
n(%)
Primary School 245(6.4) 28(6.7) 0.022
Middle School 1020(26.5) 83(19.9)
High School 1317(34.2) 168(40.3)
Some College 861(22.4) 88(21.1)
College Degree or Above 403(10.5) 50(12.0)
Marital Status, n(%)
Married 2549(65.7) 270(63.8) 0.447
Unmarried 1332(34.3) 153(36.2)
Maternal Ethnicity, n(%)
Black 1998(51.4) 259(61.1) 0.002
White 444(11.4) 39(9.2)
Hispanic 968(24.9) 84(19.8)
Other 480(12.3) 42(9.9)
Parity, n(%)
0 1559(40.1) 204(48.1) 0.001
>=1 2331(59.9) 220(51.9)
Maternal smoking, n(%)
Never 3061(78.7) 361(85.1) <0.001
Intermittent 264(6.8) 34(8.0)
Persistent 565(14.5) 29(6.8)
Passive Smoking, n(%)
No 2961(76.1) 337(79.5) 0.121
Yes 929(23.9) 87(20.5)
Maternal Illicit Drug Use, n(%)
No 3356(86.3) 379(89.4) 0.074
Yes 534(13.7) 45(10.6)
Maternal Alcohol Use, n(%)
No 3736(96.0) 415(97.9) 0.060
Yes 154(4.0) 9(2.1)
Preterm Birth, n(%)
No 2964(76.2) 167(39.4) <0.001
Yes 926(23.8) 257(60.6)
Low Birth Weight Delivery, n(%)
No 2506(64.4) 208(49.1) <0.001
Yes 1384(35.6) 216(50.9)
Chronic Hypertension, n(%)
No 3787(97.4) 318(75.0) <0.001
Yes 103(2.6) 106(25.0)

Table 2 presents the distribution of stress-related variables in the two groups. Women with preeclampsia had higher perceived levels of general stress in their lives, and also higher perceived stress during pregnancy. They also had higher job-related stress during the first and second trimester compared to those without preeclampsia, and experienced more major stressful events within 1 year prior to pregnancy. The distributions of the other stress variables were similar in the two groups.

Table 2.

Stress-Related Variables in the Study Population

Variable Level No Preeclampsia
n(%)
Preeclampsia
n(%)
P
N 3890 424
Life stressψ Low 3460(88.9) 345(81.4) <0.001
High 430(11.1) 79(18.6)
Pregnancy stressΘ Low 3126(80.4) 310(73.1) <0.001
High 764(19.6) 114(26.9)
Job stress during 1st
and 2nd trimester
Low 3074(79.0) 308(72.6) 0.002
High 816(21.0) 116(27.4)
Job stress during 3rd
trimester
Low 3357(86.3) 359(84.7) 0.357
High 533(13.7) 65(15.3)
Event within 1 year* No 3381(86.9) 349(82.3) 0.009
Yes 509(13.1) 75(17.7)
Event during
pregnancy#
No 3026(77.8) 325(76.7) 0.593
Yes 864(22.2) 99(23.3)
Violence& No 3695(95.0) 410(96.7) 0.119
Yes 195(5.0) 14(3.3)
Father involved Low 976(25.1) 101(23.8) 0.566
High 2914(74.9) 323(76.2)
Father supportive§ Low 967(24.9) 96(22.6) 0.314
High 2923(75.1) 328(77.4)
Family supportive£ Low 349(9.0) 27(6.4) 0.071
High 3541(91.0) 397(93.6)
Planned pregnancyΔ Yes 2059(52.9) 227(53.5) 0.812
No 1831(47.1) 197(46.5)
Annual household
income
<$15k 1216(43.9) 132(42.0) 0.308
$15~ k 726(26.2) 75(23.9)
>=$30k 831(30.0) 107(34.1)
Food supply Sufficient 3557(91.4) 386(91.0) 0.779
Insufficient 333(8.6) 38(9.0)
ψ

Amount of stress in mother’s life in general

Θ

Amount of stress in mother’s life during pregnancy

*

Major stressful events within 1 year prior to pregnancy

#

Major stressful events during pregnancy

&

Any violence witnessed during pregnancy

Father of baby involved in index pregnancy

§

father of baby support

£

Family and friends support

Δ

Mother wanted to become pregnant at this time

The association of chronic hypertension, life stress, pregnancy stress, and either general life stress or pregnancy stress with the risk of preeclampsia were evaluated for the entire study population (Table 3). After adjusting for potential confounding variables, the risk of preeclampsia was increased by life stress (OR (95%CI) = 2.2 (1.6–2.9), P=6.0×10−6), stress during pregnancy (1.62 (1.3–2.1), P=1.8×10−4), and chronic hypertension (10.6 (7.7–14.6), P=4.9×10−46). Additionally, having either general life stress or pregnancy stress also increased the risk of preeclampsia (OR (95%CI) = 1.6(1.3–2.1); P =1.5×10−4). Meanwhile, in the sub-analyses based on maternal ethnicity (Supplement Table 2), the strength of the association between chronic hypertension, life stress, pregnancy stress and either general life stress or pregnancy stress with the risk of preeclampsia among black mothers and non-black mothers was highly similar to those in the entire study sample.

Table 3.

The Adjusted* Associations of Chronic Hypertension, Life Stress, Pregnancy Stress and any one of Life and Pregnancy Stress with the Risk of Preeclampsia Among the Whole Sample.

Variable Preeclampsia
n(%)
No
Preeclampsia
n(%)
OR(95%CI) P
Life stress
Low 345(9.1) 3460(90.9) 1.0 --
High 79(15.5) 430(84.5) 2.1(1.5–2.8) 1.6×10−6
Pregnancy stress
Low 310(9) 3126(91) 1.0 --
High 114(13) 764(87) 1.6(1.3–2.1) 1.8×10−4
Either life or pregnancy stress
Low 301(8.9) 3063(91.1) 1.0 --
High 123(12.9) 827(87.1) 1.6(1.3–2.1) 1.5×10−4
Chronic hypertension
No 318(7.7) 3787(92.3) 1.0 --
Yes 106(50.7) 103(49.3) 10.9(7.7–14.6) 4.9×10−46
*

Covariates included maternal ethnicity, maternal active and passive smoking during pregnancy, maternal age, pre-pregnancy BMI, parity, drug use and alcohol use. Additionally, chronic hypertension was included as a covariate when the associations of life stress, pregnancy stress and either one with preeclampsia were analyzed; life stress and pregnancy stress were included as covariates when the associations of chronic hypertension with preeclampsia were analyzed.

Tables 4a and 4b present the joint association between stress and chronic hypertension in the entire study population, and in black and non-black subgroups. Mothers with both chronic hypertension and high stress had a high risk of preeclampsia. Normotensive mothers with high life stress, and chronic hypertensive mothers with either low or high life stress, had an increased risk of preeclampsia as compared with normotensive mothers with low life stress. Notably, the combination of high life stress and chronic hypertension yielded the highest risk of preeclampsia (OR (95%CI) = 21.3 (10.3–44.3); P = 2.3×10−16). Hypertensive mothers with both life stress and pregnancy stress also had a markedly high increased risk of preeclampsia with an (OR=21.5, 95% CI = 9.6 – 47.8). The joint effect of stress during pregnancy, having either general life stress or pregnancy stress with chronic hypertension on preeclampsia was very similar (Table 4). The mothers with chronic hypertension and high stress during pregnancy had a 17.4-fold (95% CI = 9.5 – 31.8) increased risk of preeclampsia, compared with normotensive mothers with low stress during pregnancy. Additionally, the joint effects of psychological stress and chronic hypertension on preeclampsia were also observed among black mothers and non-black mothers, respectively, except for the association of chronic hypertension and stress during pregnancy on preeclampsia among black mothers (Supplement Table 3).

Table 4.

The Joint* Associations of Life Stress vs. Chronic Hypertension and Stress During Pregnancy vs. Chronic Hypertension with the Risk of Preeclampsia Among all Mothers.

Variable Preeclampsia
n(%)
No
Preeclampsia
n(%)
OR(95%CI) P
Hypertension Life stress
No Low 262(7.2) 3370(92.8) 1.0 --
High 56(11.8) 417(88.2) 2.1(1.5–2.9) 7.4×10−6
Yes Low 83(48.0) 90(52.0) 10.6(7.5–15.1) 1.4×10−39
High 23(63.9) 13(36.1) 21.3(10.3–44.3) 2.3×10−16
Hypertension Stress during pregnancy
No Low 235(7.2) 3044(92.8) 1.0 --
High 83(10.0) 743(90.0) 1.6(1.2–2.1) 5.3×10−4
Yes Low 75(47.8) 82(52.2) 10.6(7.4–15.4) 1.9×10−36
High 31(59.6) 21(40.4) 17.4(9.5–31.8) 1.8×10−20
Hypertension Any one of life and pregnancy stress
No Low 230(7.2) 2983(92.8) 1.0 --
High 88(9.9) 804(90.1) 1.6(1.2–2.1) 5.7×10−4
Yes Low 71(47.0) 80(53.0) 10.4
(7.165–15.1)
1.3×10−34
High 35(60.3) 23(39.7) 17.7(10.0–31.5) 1.2×10−22
Hypertension Both life and pregnancy stress
No Low 230(7.2) 2983(92.8) 1.0 .--
High 51(12.5) 356(87.5) 2.3(1.6–3.2) 2.3×10−6
Yes Low 71(47.0) 80(53.0) 10.3(7.1–15.0) 6.5×10−34
High 19(63.3) 11(36.7) 21.5(9.6–47.8) 5.9×10−14
*

Covariates included maternal ethnicity, maternal active and passive smoking during pregnancy, maternal age, pre-pregnancy BMI, parity, drug use and alcohol use.

Discussion

This study found that perceived general lifetime stress, stress during pregnancy, and chronic hypertension were associated with an increased risk of preeclampsia. A critical finding was that chronic hypertension, in combination with high stress before or during pregnancy, was associated with a dramatically increased risk of preeclampsia. Compared with normotensive women with low life stress and low stress during pregnancy, the adjusted odds ratio (OR) of hypertensive mothers with high life stress or high stress during pregnancy reached to 21.3 and 17.4, respectively. Furthermore, in the sub-analyses of black mothers and non-black mothers, the joint association of CH and perceived stress on the risk of preeclampsia was basically consistent with that from the entire study sample.

Chronic hypertension is a relatively common and increasingly prevalent comorbidity in pregnancy. Recent U.S. data have shown that the age-adjusted prevalence of all-cause chronic hypertension increased significantly throughout the seven 2-year intervals, from 1.01% in 1995–1996 to 1.76% in 2007–200830. Our results revealed that chronic hypertension is associated with an elevated risk of preeclampsia (OR = 10.9, 95% CI = 7.7–14.6), a finding that is consistent with the results of other investigators5,31. Whereas the ORs of chronic hypertension relative to the development of preeclampsia from different studies have varied from 2.21 to 19.5 5,30,31, all human epidemiological studies have consistently shown that chronic hypertension increases the risk of preeclampsia 5,30,31. Moreover, separate analyses of black and non-black mothers showed results similar to those from the entire study population, which indicates that the association of chronic hypertension with preeclampsia was very stable. As well, the clinical data indicated that controlling blood pressure can decrease the risk of preeclampsia among pregnant women with chronic hypertension. It also showed that chronic hypertension was associated with an increased risk of preeclampsia.

Thus far, our understanding of whether psychological stress is related to an increased risk for preeclampsia is controversial. It has been hypothesized that preeclampsia is, in part, a stress-related disease, and epidemiologic studies have shown that the relative risk for preeclampsia increases in relation to the number of stressful situations experienced32. Our findings suggest that psychological stress, in general or during pregnancy, is moderately associated with an increased risk of preeclampsia -- findings that are similar to previous studies15,16,31. For example, a prospective cohort study found that anxiety in early pregnancy was associated with a 3.2-fold increased risk for subsequent preeclampsia among mothers in the Helsinki metropolitan area15. Another study found a positive history of maternal mood or anxiety disorder was associated with a 2.12-fold increased risk of preeclampsia16. Stressful work or home environments were also found to be associated with an increased risk of preeclampsia31, and pregnant women with worsening or severe preeclampsia/severe gestational hypertension were found to have higher psychological stress than those with mild preeclampsia/mild gestational hypertension33. Conversely, in a study conducted in Amsterdam, there was no significant association between work stress, anxiety, depression or early pregnancy-related anxiety and the development of gestational hypertension or preeclampsia later in pregnancy23. Similarly, two other prospective studies did not find an association between depression or anxiety and hypertensive complications of pregnancy24,25. A further case-control study conducted in Canada also found no association between job stress and preeclampsia34.

Known neuropsychoimmunological mechanisms may begin to account for a causal relationship between stress and preeclampsia. Psychological stress activates the hypothalamus–pituitary–adrenal (HPA) axis, which in turn increases blood levels of corticosteroids and catecholamines, hormones that are produced in the adrenal glands in the case of psychological or physiological stress. Stress also activates the sympathetic nervous system and has been found to influence immune system function35,36. In accordance with these findings, increased blood levels of corticotrophin-releasing hormone and increased sympathetic activity have been observed in women with preeclampsia37.

Our most compelling finding was that the combination of stress and chronic hypertension is associated with a 20-fold increase in the risk of preeclampsia. The hypertensive mother with either high general life stress and pregnancy stress, or the combination of both, had up to a 39.7-fold (95% CI = 8.5 – 184.4) increased risk of preeclampsia. Importantly, the findings from the entire study sample were confirmed by analyses performed on individual ethnic sub-groups.

This is the first study to examine the combined effects of psychological stress and chronic hypertension on the incidence of preeclampsia. With this stated, there is mounting evidence that chronic hypertension and psychological stress are associated individually with an increased risk of preeclampsia -- almost all previous studies suggest that chronic hypertension is positively related to the risk of preeclampsia. There are plausible mechanisms by which the synergistic influences of psychological stress and chronic hypertension could contribute to the development of preeclampsia. For example, psychological stress can lead to sympathetic over-activity in the hypothalamic-pituitary-adrenal (HPA) axis, and the resulting increase in sympathetic activity may contribute to vasoconstriction -- the key abnormality in preeclampsia. Understanding the effects of stress during human pregnancy is complicated by the development of the placenta as a significant endocrine organ that may be highly "stress-sensitive"38,39. All HPA-axis peptides increase during human gestation, but the dramatic elevations of placental corticotropin-releasing hormone (CRH) in maternal plasma during pregnancy reach levels observed only in the hypothalamic portal system during physiological stress40. Stress is also indicated in the pathogenesis of chronic hypertension41.

Pregnant black women have a greater risk of preeclampsia and chronic hypertension, particularly Americans of West African origin42. The high prevalence of chronic hypertension in blacks can be partly explained by the individual social and racial status of living in the U.S.; such psychosocial stress may evoke neuroendocrine responses favoring an increase in arterial pressure43. Moreover, depression and anxiety during pregnancy could prove harmful through the altered excretion of vasoactive hormones or other neuroendocrine transmitters4447, which in turn may increase the risk for hypertension.

Relative to the sympathetic nervous system, Schobel et al.48 observed a greater increase in activity in pregnant women with preeclampsia than in normotensive pregnant and non-pregnant women. Because sympathetic nervous system activity has been found to revert to normal in some pregnant women with preeclampsia, it has been hypothesized that preeclampsia is a state of increased sympathetic activity. As well, stress can have its effects on individuals via an increase in sympathetic vasoconstrictor activity. For example, women experiencing high levels of stress during pregnancy have increased circulating levels of proinflammatory cytokines relative to women who do not report high levels of prenatal stress49. This is a potentially critical observation, since increased levels of pro-inflammatory cytokines and decreased amounts of anti-inflammatory cytokines have been associated with the occurrence of preeclampsia50. Moreover, an increase in pro-inflammatory cytokines is associated with the general occurrence of hypertension in humans51. Hence, psychological stress combined with chronic hypertension via the inflammatory cytokine pathway may also drive the occurrence of preeclampsia during pregnancy. Our study reveals a synergistic effect between perceived stress and chronic hypertension, resulting in a strongly increased risk of preeclampsia. This key data can be harnessed to inform clinical practice. Currently, prevention of preeclampsia focuses primarily on lowering blood pressure, and does not generally address the reduction of psychological stress. We suggest that efforts to control stress during pregnancy could decrease the risk of preeclampsia.

Our study has the following limitations. First, levels of general life stress and pregnancy stress were recalled by the mothers in our study after delivery and could be subject to recall bias. Second, both the duration and period of psychological stress may have different effects on preeclampsia; however, information about duration and period of psychological stress was not obtained in this study, thus hampers further exploration into the effects of psychological stress on preeclampsia. Third, other psychological disorders (e.g., neurosis), which were not identified in our study, might distort the joint association of psychological stress and chronic hypertension with preeclampsia. Fourth, while each type of psychological stress was determined by only a single question in the questionnaire, it is possible that this may better reflect stress than more comprehensive measures of stress load (e.g. life event scales). Moreover, it is possible that a single question may make interpretation of the results more distinct than a conglomerate of combined items and questions. Our question on stress has been used in several previous studies and found to be related to indicated increased risk for dementia52, hypertension 53, cancer54 and psychosomatic diseases55.

In summary, we studied an urban, predominantly minority, population, and found that high perceived stress and chronic hypertension interact synergistically to increase the risk of preeclampsia up to 40-fold. Given the high prevalence of these risk factors in the general population, we propose that a substantial reduction in the incidence of preeclampsia might be gained through effective control of maternal stress and hypertension, both pre-pregnancy and throughout the gestational period. While further research to validate the efficacy of such interventions is needed, this research holds great promise and tremendous potential to yield substantial human and economic benefits.

Acknowledgements

Source of Funding

The study is supported in part by the March of Dimes PERI grants (PI: Wang, 20-FY02-56), the NIEHS (PI: Wang, R21 ES011666), and the NICHD (PI: Wang, R01 HD041702, R21HD066471). We also wish to thank all of the study participants, and the Boston Medical Center Labor and Delivery Nursing Staff for their support and help with the study. We thank Lingling Fu, MS, for data management; Ann Ramsey for administrative support; and the dedication and hard work of the field team at the Department of Pediatrics, Boston University School of Medicine.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Conflicts of interests

The authors have declared that no conflicting interests exist.

REFERENCES

  • 1.Curtin WM, Weinstein L. A review of HELLP syndrome. J Perinatol. 1999 Mar;19(2):138–143. doi: 10.1038/sj.jp.7200165. [DOI] [PubMed] [Google Scholar]
  • 2.Ness RB, Roberts JM. Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol. 1996 Nov;175(5):1365–1370. doi: 10.1016/s0002-9378(96)70056-x. [DOI] [PubMed] [Google Scholar]
  • 3.Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006 Apr 1;367(9516):1066–1074. doi: 10.1016/S0140-6736(06)68397-9. [DOI] [PubMed] [Google Scholar]
  • 4.HC. Special report on maternal mortality and severe morbidity in Canada enhanced surveillance: the path to prevention, Minister of Public Works and Government Services. Canada: Ottawa; 2004. [Google Scholar]
  • 5.Luealon P, Phupong V. Risk factors of preeclampsia in Thai women. J Med Assoc Thai. 2010 Jun;93(6):661–666. [PubMed] [Google Scholar]
  • 6.Sibai BM. Treatment of hypertension in pregnant women. N Engl J Med. 1996 Jul 25;335(4):257–265. doi: 10.1056/NEJM199607253350407. [DOI] [PubMed] [Google Scholar]
  • 7.Sibai BM, Lindheimer M, Hauth J, et al. Risk factors for preeclampsia, and abruptio placentae adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 1998 Sep 3;339(10):667–671. doi: 10.1056/NEJM199809033391004. [DOI] [PubMed] [Google Scholar]
  • 8.Wang L, Feng Y, Zhang Y, et al. Prolylcarboxypeptidase gene, chronic hypertension, and risk of preeclampsia. Am J Obstet Gynecol. 2006 Jul;195(1):162–171. doi: 10.1016/j.ajog.2006.01.079. [DOI] [PubMed] [Google Scholar]
  • 9.Orr ST, Reiter JP, Blazer DG, James SA. Maternal prenatal pregnancy-related anxiety and spontaneous preterm birth in Baltimore, Maryland. Psychosom Med. 2007 Jul-Aug;69(6):566–570. doi: 10.1097/PSY.0b013e3180cac25d. [DOI] [PubMed] [Google Scholar]
  • 10.Catov JM, Abatemarco DJ, Markovic N, Roberts JM. Anxiety and Optimism Associated with Gestational Age at Birth and Fetal Growth. Matern Child Health J. 2009 Aug 21; doi: 10.1007/s10995-009-0513-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Orr ST, James SA, Blackmore Prince C. Maternal prenatal depressive symptoms and spontaneous preterm births among African-American women in Baltimore, Maryland. Am J Epidemiol. 2002 Nov 1;156(9):797–802. doi: 10.1093/aje/kwf131. [DOI] [PubMed] [Google Scholar]
  • 12.Hoffman S, Hatch MC. Depressive symptomatology during pregnancy: evidence for an association with decreased fetal growth in pregnancies of lower social class women. Health Psychol. 2000 Nov;19(6):535–543. [PubMed] [Google Scholar]
  • 13.Berle JO, Mykletun A, Daltveit AK, Rasmussen S, Holsten F, Dahl AA. Neonatal outcomes in offspring of women with anxiety and depression during pregnancy A linkage study from The Nord-Trondelag Health Study (HUNT) and Medical Birth Registry of Norway. Arch Womens Ment Health. 2005 Sep;8(3):181–189. doi: 10.1007/s00737-005-0090-z. [DOI] [PubMed] [Google Scholar]
  • 14.Cookson H, Granell R, Joinson C, Ben-Shlomo Y, Henderson AJ. Mothers' anxiety during pregnancy is associated with asthma in their children. J Allergy Clin Immunol. 2009 Apr;123(4):847–853. doi: 10.1016/j.jaci.2009.01.042. e811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Kurki T, Hiilesmaa V, Raitasalo R, Mattila H, Ylikorkala O. Depression and anxiety in early pregnancy and risk for preeclampsia. Obstet Gynecol. 2000 Apr;95(4):487–490. doi: 10.1016/s0029-7844(99)00602-x. [DOI] [PubMed] [Google Scholar]
  • 16.Qiu C, Williams MA, Calderon-Margalit R, Cripe SM, Sorensen TK. Preeclampsia risk in relation to maternal mood and anxiety disorders diagnosed before or during early pregnancy. Am J Hypertens. 2009 Apr;22(4):397–402. doi: 10.1038/ajh.2008.366. [DOI] [PubMed] [Google Scholar]
  • 17.Klonoff-Cohen HS, Cross JL, Pieper CF. Job stress and preeclampsia. Epidemiology. 1996 May;7(3):245–249. doi: 10.1097/00001648-199605000-00005. [DOI] [PubMed] [Google Scholar]
  • 18.Marcoux S, Berube S, Brisson C, Mondor M. Job strain and pregnancy-induced hypertension. Epidemiology. 1999 Jul;10(4):376–382. doi: 10.1097/00001648-199907000-00004. [DOI] [PubMed] [Google Scholar]
  • 19.Landsbergis PA, Hatch MC. Psychosocial work stress and pregnancy-induced hypertension. Epidemiology. 1996 Jul;7(4):346–351. doi: 10.1097/00001648-199607000-00002. [DOI] [PubMed] [Google Scholar]
  • 20.Wergeland E, Strand K. Working conditions and prevalence of pre-eclampsia, Norway 1989. Int J Gynaecol Obstet. 1997 Aug;58(2):189–196. doi: 10.1016/s0020-7292(97)00083-0. [DOI] [PubMed] [Google Scholar]
  • 21.Shamsi U, Hatcher J, Shamsi A, Zuberi N, Qadri Z, Saleem S. A multicentre matched case control study of risk factors for preeclampsia in healthy women in Pakistan. BMC Womens Health. 2010;10:14–16. doi: 10.1186/1472-6874-10-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Takiuti NH, Kahhale S, Zugaib M. Stress in pregnancy: a new Wistar rat model for human preeclampsia. Am J Obstet Gynecol. 2002 Mar;186(3):544–550. doi: 10.1067/mob.2002.121102. [DOI] [PubMed] [Google Scholar]
  • 23.Vollebregt KC, van der Wal MF, Wolf H, Vrijkotte TG, Boer K, Bonsel GJ. Is psychosocial stress in first ongoing pregnancies associated with pre-eclampsia and gestational hypertension? Bjog. 2008 Apr;115(5):607–615. doi: 10.1111/j.1471-0528.2008.01665.x. [DOI] [PubMed] [Google Scholar]
  • 24.Andersson L, Sundstrom-Poromaa I, Wulff M, Astrom M, Bixo M. Implications of antenatal depression and anxiety for obstetric outcome. Obstet Gynecol. 2004 Sep;104(3):467–476. doi: 10.1097/01.AOG.0000135277.04565.e9. [DOI] [PubMed] [Google Scholar]
  • 25.Sikkema JM, Robles de Medina PG, Schaad RR, et al. Salivary cortisol levels and anxiety are not increased in women destined to develop preeclampsia. J Psychosom Res. 2001 Jan;50(1):45–49. doi: 10.1016/s0022-3999(00)00208-7. [DOI] [PubMed] [Google Scholar]
  • 26.Hamill PV, Drizd TA, Johnson CL, Reed RB, Roche AF, Moore WM. Physical growth: National Center for Health Statistics percentiles. Am J Clin Nutr. 1979 Mar;32(3):607–629. doi: 10.1093/ajcn/32.3.607. [DOI] [PubMed] [Google Scholar]
  • 27.Wang X, Zuckerman B, Pearson C, et al. Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. Jama. 2002 Jan 9;287(2):195–202. doi: 10.1001/jama.287.2.195. [DOI] [PubMed] [Google Scholar]
  • 28.Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004 Feb 12;350(7):672–683. doi: 10.1056/NEJMoa031884. [DOI] [PubMed] [Google Scholar]
  • 29.Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000 Jul;183(1):S1–S22. [PubMed] [Google Scholar]
  • 30.Bateman BT, Bansil P, Hernandez-Diaz S, Mhyre JM, Callaghan WM, Kuklina EV. Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions. Am J Obstet Gynecol. 2012 Feb;206(2):134. doi: 10.1016/j.ajog.2011.10.878. e131–138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Anorlu RI, Iwuala NC, Odum CU. Risk factors for pre-eclampsia in Lagos, Nigeria. Aust N Z J Obstet Gynaecol. 2005 Aug;45(4):278–282. doi: 10.1111/j.1479-828X.2005.00411.x. [DOI] [PubMed] [Google Scholar]
  • 32.Takiuti NH, Kahhale S, Zugaib M. Stress-related preeclampsia: an evolutionary maladaptation in exaggerated stress during pregnancy? Med Hypotheses. 2003 Mar;60(3):328–331. doi: 10.1016/s0306-9877(02)00393-6. [DOI] [PubMed] [Google Scholar]
  • 33.Black KD. Stress, symptoms, self-monitoring confidence, well-being, and social support in the progression of preeclampsia/gestational hypertension. J Obstet Gynecol Neonatal Nurs. 2007 Sep-Oct;36(5):419–429. doi: 10.1111/j.1552-6909.2007.00173.x. [DOI] [PubMed] [Google Scholar]
  • 34.Haelterman E, Marcoux S, Croteau A, Dramaix M. Population-based study on occupational risk factors for preeclampsia and gestational hypertension. Scand J Work Environ Health. 2007 Aug;33(4):304–317. doi: 10.5271/sjweh.1147. [DOI] [PubMed] [Google Scholar]
  • 35.Mulder EJ, Robles de Medina PG, Huizink AC, Van den Bergh BR, Buitelaar JK, Visser GH. Prenatal maternal stress: effects on pregnancy and the (unborn) child. Early Hum Dev. 2002 Dec;70(1–2):3–14. doi: 10.1016/s0378-3782(02)00075-0. [DOI] [PubMed] [Google Scholar]
  • 36.Coussons-Read ME, Okun ML, Nettles CD. Psychosocial stress increases inflammatory markers and alters cytokine production across pregnancy. Brain Behav Immun. 2007 Mar;21(3):343–350. doi: 10.1016/j.bbi.2006.08.006. [DOI] [PubMed] [Google Scholar]
  • 37.Perkins AV, Linton EA, Eben F, Simpson J, Wolfe CD, Redman CW. Corticotrophin-releasing hormone and corticotrophin-releasing hormone binding protein in normal and pre-eclamptic human pregnancies. Br J Obstet Gynaecol. 1995 Feb;102(2):118–122. doi: 10.1111/j.1471-0528.1995.tb09063.x. [DOI] [PubMed] [Google Scholar]
  • 38.Jones SA, Brooks AN, Challis JR. Steroids modulate corticotropin-releasing hormone production in human fetal membranes and placenta. J Clin Endocrinol Metab. 1989 Apr;68(4):825–830. doi: 10.1210/jcem-68-4-825. [DOI] [PubMed] [Google Scholar]
  • 39.Petraglia F, Aguzzoli L, Florio P, et al. Maternal plasma and placental immunoreactive corticotrophin-releasing factor concentrations in infection-associated term and pre-term delivery. Placenta. 1995 Mar;16(2):157–164. doi: 10.1016/0143-4004(95)90004-7. [DOI] [PubMed] [Google Scholar]
  • 40.Duclow DF. Perspective and therapy in Boethius's Consolation of Philosophy. J Med Philos. 1979 Sep;4(3):334–343. doi: 10.1093/jmp/4.3.334. [DOI] [PubMed] [Google Scholar]
  • 41.Kaplan NM. Heart Disease: A Textbook of Cardiovascular Medicine. 4th Edn ed. Philadelphia: WB Saunders Company; 1992. [Google Scholar]
  • 42.Wilson TW, Hollifield LR, Grim CE. Systolic blood pressure levels in black populations in sub-Sahara Africa, the West Indies, and the United States: a meta-analysis. Hypertension. 1991 Sep;18(3 Suppl):I87–I91. doi: 10.1161/01.hyp.18.3_suppl.i87. [DOI] [PubMed] [Google Scholar]
  • 43.Grim CE, Henry JPHM. Hypertension – Pathophysiology, Diagnosis and Management. 2nd Edn ed. New York: Raven Press; 1995. [Google Scholar]
  • 44.Lewinsky RM, Riskin-Mashiah S. Autonomic imbalance in preeclampsia: evidence for increased sympathetic tone in response to the supine-pressor test. Obstet Gynecol. 1998 Jun;91(6):935–939. doi: 10.1016/s0029-7844(98)00105-7. [DOI] [PubMed] [Google Scholar]
  • 45.Paarlberg KM, Vingerhoets AJ, Passchier J, Dekker GA, Van Geijn HP. Psychosocial factors and pregnancy outcome: a review with emphasis on methodological issues. J Psychosom Res. 1995 Jul;39(5):563–595. doi: 10.1016/0022-3999(95)00018-6. [DOI] [PubMed] [Google Scholar]
  • 46.Wadhwa PD, Dunkel-Schetter C, Chicz-DeMet A, Porto M, Sandman CA. Prenatal psychosocial factors and the neuroendocrine axis in human pregnancy. Psychosom Med. 1996 Sep-Oct;58(5):432–446. doi: 10.1097/00006842-199609000-00006. [DOI] [PubMed] [Google Scholar]
  • 47.Sandman CA, Wadhwa PD, Chicz-DeMet A, Dunkel-Schetter C, Porto M. Maternal stress, HPA activity, and fetal/infant outcome. Ann N Y Acad Sci. 1997 Apr 24;814:266–275. doi: 10.1111/j.1749-6632.1997.tb46162.x. [DOI] [PubMed] [Google Scholar]
  • 48.Schobel HP, Fischer T, Heuszer K, Geiger H, Schmieder RE. Preeclampsia -- a state of sympathetic overactivity. N Engl J Med. 1996 Nov 14;335(20):1480–1485. doi: 10.1056/NEJM199611143352002. [DOI] [PubMed] [Google Scholar]
  • 49.Coussons-Read ME, Okun ML, Schmitt MP, Giese S. Prenatal stress alters cytokine levels in a manner that may endanger human pregnancy. Psychosom Med. 2005 Jul-Aug;67(4):625–631. doi: 10.1097/01.psy.0000170331.74960.ad. [DOI] [PubMed] [Google Scholar]
  • 50.Piccinni MP, Maggi E, Romagnani S. Role of hormone-controlled T-cell cytokines in the maintenance of pregnancy. Biochem Soc Trans. 2000 Feb;28(2):212–215. doi: 10.1042/bst0280212. [DOI] [PubMed] [Google Scholar]
  • 51.Bautista LE, Vera LM, Arenas IA, Gamarra G. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J Hum Hypertens. 2005 Feb;19(2):149–154. doi: 10.1038/sj.jhh.1001785. [DOI] [PubMed] [Google Scholar]
  • 52.Johansson L, Guo X, Waern M, et al. Midlife psychological stress and risk of dementia: a 35-year longitudinal population study. Brain. 2010 Aug;133(Pt 8):2217–2224. doi: 10.1093/brain/awq116. [DOI] [PubMed] [Google Scholar]
  • 53.Eriksson H, Svardsudd K, Larsson B, et al. Risk factors for heart failure in the general population: the study of men born in 1913. Eur Heart J. 1989 Jul;10(7):647–656. doi: 10.1093/oxfordjournals.eurheartj.a059542. [DOI] [PubMed] [Google Scholar]
  • 54.Helgesson O, Cabrera C, Lapidus L, Bengtsson C, Lissner L. Self-reported stress levels predict subsequent breast cancer in a cohort of Swedish women. Eur J Cancer Prev. 2003 Oct;12(5):377–381. doi: 10.1097/00008469-200310000-00006. [DOI] [PubMed] [Google Scholar]
  • 55.Hange D, Bengtsson C, Sundh V, Bjorkelund C. The natural history of psychosomatic symptoms and their association with psychological symptoms: observations from the Population Study of Women in Gothenburg. Eur J Gen Pract. 2007;13(2):60–66. doi: 10.1080/13814780701377497. [DOI] [PubMed] [Google Scholar]

RESOURCES